Characteristics | Total | Deceased | Living | |||
n | % | n | % | n | % | |
Age (years) Mean (standard deviation) | 56 years (17) | 58 years (17) | 54 years (17) | |||
Age range (years) |
|
|
|
|
|
|
≤30 | 9 | 7.3 | 2 | 22.2 | 7 | 78.2 |
]30 - 60] | 57 | 46 | 26 | 45.6 | 3 | 54.4 |
≥60 | 58 | 46.8 | 31 | 53.4 | 27 | 46.6 |
Sex |
|
|
|
|
|
|
Female | 40 | 31.5 | 22 | 55 | 18 | 45 |
Male | 85 | 66.9 | 39 | 45.9 | 46 | 54.1 |
Comorbidities |
|
|
|
|
|
|
HTA | 61 | 48 | 27 | 44.3 | 34 | 55.7 |
Diabetes | 44 | 34.6 | 26 | 59.1 | 18 | 40.9 |
Obesity | 8 | 6.3 | 3 | 37.5 | 5 | 62.5 |
STROKE | 12 | 9.4 | 6 | 50 | 6 | 50 |
Cardiopathy | 7 | 5.5 | 1 | 14.3 | 6 | 85.7 |
Clinical parameters |
|
|
|
|
|
|
Fever | 47 | 37 | 25 | 53.2 | 22 | 46.8 |
Dyspnea | 71 | 55.9 | 36 | 50.7 | 35 | 49.3 |
Hypotension | 5 | 4.7 | 2 | 40 | 3 | 60 |
SaO2 (%) < 90 | 44 | 39.6 | 30 | 68.2 | 14 | 31.8 |
Impaired GC | 56 | 44.1 | 35 | 62.5 | 21 | 37.5 |
Covid Severity |
|
|
|
|
|
|
Asymptomatic | 3 | 2.4 | 0 | 0 | 3 | 100 |
Mild | 7 | 5.5 | 1 | 14.3 | 6 | 85.7 |
Moderate | 42 | 33.1 | 13 | 31 | 29 | 69 |
Severe | 41 | 32.3 | 28 | 68.3 | 13 | 31.7 |
Critical | 12 | 9.4 | 12 | 100 | 0 | 0 |
eGFR (ml/min/1.73m2) |
|
|
|
|
|
|
>90 | 2 | 1.6 | 0 | 0 | 2 | 100 |
]60 - 90] | 22 | 17.9 | 5 | 22.7 | 17 | 77.3 |
]45 - 60] | 16 | 13 | 4 | 25 | 12 | 75 |
]30 - 45] | 18 | 14.6 | 7 | 38.9 | 11 | 61.1 |
]15 - 30] | 23 | 18.7 | 12 | 52.5 | 11 | 47.8 |
≤15 | 42 | 34.1 | 30 | 71.4 | 12 | 28.6 |
Other parameters |
|
|
|
|
|
|
Hyperglycaemia | 22 | 21.4 | 16 | 72,7 | 6 | 27.3 |
Hepatic cytolysis | 96 | 82.1 | 49 | 51 | 47 | 49 |
Anaemia | 60 | 50.8 | 33 | 55 | 27 | 45 |
Hyperkalaemia | 17 | 12.5 | 12 | 70.6 | 5 | 29.4 |
Antibiotics | 114 | 89.8 | 55 | 48.2 | 59 | 51.8 |
Corticosteroids | 39 | 30.5 | 25 | 64.1 | 14 | 35.9 |
Anticoagulant | 88 | 69.3 | 47 | 53.4 | 41 | 46.6 |
Dialysis | 17 | 13.4 | 9 | 52.9 | 8 | 47.1 |
Length of hospitalization < 7 days | 55 | 47.4 | 43 | 78.2 | 12 | 21.8 |